Literature DB >> 12749874

Myocardial performance index as predictor of adverse outcomes following mitral valve surgery.

M Al-Mukhaini1, S Argentin, J-F Morin, C Benny, D Cusson, T Huynh.   

Abstract

AIMS: We aim to determine whether the myocardial performance index, will be a good predictor of adverse outcomes following mitral valve surgery.
METHOD: We prospectively measured pre-operative myocardial performance index in 22 consecutive patients, with moderate to severe mitral insufficiency, undergoing corrective mitral valve surgery. The primary endpoint was predefined as either peri-operative death or congestive heart failure.
RESULTS: The primary endpoint occurred in nine patients. Five of the six patients with myocardial performance index >or=0.7 had primary endpoints. Chi-square testing demonstrated that the primary endpoint was significantly associated with advanced age (>or=70 years) and myocardial performance index >or=0.7 (P=0.003 and 0.01 respectively). There was a trend towards significant association of depressed left ventricle ejection fraction (left ventricle ejection fraction <or=40%) and the primary endpoint (P=0.09). Although left ventricle ejection fraction <or=40% was more sensitive in predicting the primary endpoint, it has lower specificity, accuracy and predictive values than myocardial performance index >or=0.7.
CONCLUSION: Our results suggest that myocardial performance index is a potentially useful predictor of increased risk of peri-operative death or congestive heart failure, in patients with moderate-severe mitral insufficiency undergoing corrective mitral valve surgery. In conjunction with left ventricle ejection fraction, it may be helpful in the pre-operative prognostication of these patients. Copyright 2002 The European Society of Cardiology, Published by Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12749874     DOI: 10.1053/euje.2002.0630

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  1 in total

1.  Pulmonary hypertension and cardiac hypertrophy in children recipients of orthotopic living related liver transplantation.

Authors:  Magd A Kotb; Inas Abd El Satar; Ahmed M Badr; Nancy H Anis; Hoda Abd El Rahman Ismail; Alaa F Hamza; Hesham M Abdelkader
Journal:  J Adv Res       Date:  2017-07-27       Impact factor: 10.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.